Renalytix Plc (AIM:RENX)
5.90
-0.10 (-1.67%)
Dec 31, 2025, 12:24 PM GMT+1
Renalytix Market Cap
Renalytix has a market cap or net worth of 25.78 million as of December 31, 2025. Its market cap has decreased by -18.05% in one year.
Market Cap
25.78M
Enterprise Value
29.14M
Revenue
2.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.90
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 25.78M, a decrease of -60.07%. That is a compound annual growth rate of -12.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 25.78M | -27.58% |
| Dec 31, 2024 | 35.60M | 129.87% |
| Dec 29, 2023 | 15.49M | -71.47% |
| Dec 30, 2022 | 54.30M | -87.89% |
| Dec 31, 2021 | 448.32M | 27.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 213.19B |
| GSK plc | 73.15B |
| Haleon | 33.22B |
| Smith & Nephew | 10.37B |
| Convatec Group | 4.64B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 1.73B |
| HUTCHMED (China) | 1.71B |